-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-10-20
CI:NYE-Cigna Corp (USD)
COMMON STOCK | Healthcare Plans |
Last Closing
USD 336Change
0.00 (0.00)%Market Cap
N/AVolume
2.71MAnalyst Target
USD 242.00N/A
Verdict
Values as of: 2024-10-20
COMMON STOCK | Healthcare Plans |
Last Closing
USD 336Change
0.00 (0.00)%Market Cap
N/AVolume
2.71MAnalyst Target
USD 242.00N/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
UNH | UnitedHealth Group Incorporate.. |
N/A |
USD 525.99B |
ELV | Elevance Health Inc |
N/A |
USD 118.03B |
CNC | Centene Corp |
N/A |
USD 32.62B |
MOH | Molina Healthcare Inc |
N/A |
USD 16.98B |
OSCR | Oscar Health Inc |
N/A |
USD 4.35B |
NEUE | NeueHealth Inc |
N/A |
USD 0.05B |
CVS | CVS Health Corp |
N/A |
N/A |
HUM | Humana Inc |
N/A |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
AILV | 4.45 % | 0.00 % |
N/A |
N/A | |
CBUF:XETRA | iShares MSCI World Health.. | 3.38 % | 0.00 % |
N/A |
USD 1.13B |
CBUF:F | iShares V Public Limited .. | 3.27 % | 0.00 % |
N/A |
N/A |
WHCS:SW | iShares MSCI World Health.. | 3.22 % | 0.00 % |
N/A |
N/A |
SHRY | First Trust Bloomberg Sha.. | 3.14 % | 0.00 % |
N/A |
USD 0.02B |
FSST | Fidelity Sustainability U.. | 2.63 % | 0.00 % |
N/A |
USD 0.02B |
ZPRU:XETRA | SPDR® MSCI USA Value UCI.. | 2.33 % | 0.00 % |
N/A |
USD 0.13B |
UVAL:SW | SPDR® MSCI USA Value UCI.. | 2.33 % | 0.00 % |
N/A |
USD 0.14B |
DSTL | Distillate US Fundamental.. | 1.59 % | 0.00 % |
N/A |
USD 2.11B |
IQSA:F | Invesco Markets II PLC - .. | 1.53 % | 0.00 % |
N/A |
N/A |
IQSE:F | Invesco Markets II PLC - .. | 1.53 % | 0.00 % |
N/A |
N/A |
IQSA:XETRA | Invesco Quantitative Stra.. | 1.46 % | 0.00 % |
N/A |
USD 0.07B |
IQSE:XETRA | Invesco Quantitative Stra.. | 1.46 % | 0.00 % |
N/A |
USD 0.05B |
DMFC:SW | iShares Edge MSCI World M.. | 1.42 % | 0.00 % |
N/A |
N/A |
IBCZ:XETRA | iShares Edge MSCI World M.. | 1.40 % | 0.00 % |
N/A |
USD 0.40B |
IS07:XETRA | iShares Edge MSCI World M.. | 1.39 % | 0.00 % |
N/A |
USD 0.01B |
IFSW:SW | iShares Edge MSCI World M.. | 1.39 % | 0.00 % |
N/A |
USD 0.60B |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
N/A |
USD 0.08B |
FUM:CA | 0.00 % | 0.80 % |
N/A |
N/A | |
IHF | iShares U.S. Healthcare P.. | 0.00 % | 0.43 % |
N/A |
N/A |
QSY | 0.00 % | 0.38 % |
N/A |
N/A | |
DUSA | 0.00 % | 0.63 % |
N/A |
N/A | |
HONR | 0.00 % | 0.65 % |
N/A |
N/A | |
BUYB:LSE | Invesco Global Buyback Ac.. | 0.00 % | 0.00 % |
N/A |
N/A |
RYH | 0.00 % | 0.40 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.00 % | 0.40 % |
N/A |
N/A |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
UVAL:LSE | SPDR® MSCI USA Value UCI.. | 0.00 % | 0.00 % |
N/A |
USD 0.14B |
XMWD:LSE | Xtrackers MSCI World Swap.. | 0.00 % | 0.00 % |
N/A |
N/A |
USVL:LSE | SPDR® MSCI USA Value UCI.. | 0.00 % | 0.00 % |
N/A |
USD 0.14B |
TPHC:PA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
N/A |
USD 9.67M |
TPXE:PA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
N/A |
USD 0.27B |
TPXH:PA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
N/A |
USD 0.22B |
IBCZ:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
N/A |
N/A |
IS07:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
N/A |
N/A |
ZPRU:F | SSgA SPDR ETFs Europe II .. | 0.00 % | 0.00 % |
N/A |
USD 0.13B |
TTPX:XETRA | Amundi Index Solutions - .. | 0.00 % | 0.00 % |
N/A |
USD 0.40B |
VGVL:XETRA | 0.00 % | 0.00 % |
N/A |
N/A | |
VMUS:XETRA | 0.00 % | 0.00 % |
N/A |
N/A | |
HDIV | 0.00 % | 0.00 % |
N/A |
N/A | |
FDWM | Fidelity Covington Trust .. | 0.00 % | 0.00 % |
N/A |
USD 4.09M |
NTZG | 0.00 % | 0.00 % |
N/A |
N/A | |
BUYB:SW | Invesco Global Buyback Ac.. | 0.00 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Healthcare Plans) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -62.60% | 38% | F | 6% | D- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -62.60% | 38% | F | 10% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -63.49% | 38% | F | 5% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -63.49% | 38% | F | 9% | A- | ||
Trailing 5 Years | |||||||
Capital Gain | -34.26% | 67% | D+ | 20% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -34.26% | 67% | D+ | 25% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 14.97% | 63% | D | 77% | C+ | ||
Dividend Return | 16.45% | 63% | D | 76% | C+ | ||
Total Return | 1.47% | 60% | D- | 34% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 20.46% | 75% | C | 51% | F | ||
Risk Adjusted Return | 80.38% | 88% | B+ | 90% | A- | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
There is nothing we particularly dislike